Therapeutic Trifecta
Published on: 21/01/2019
With a promising cannabinoid pipeline, an alternative to the EpiPen, and a superior solution for opioid overdoses, this firm has moved in on not one but three
Biotech InvestmentsCannabinoid PipelineEpiPen AlternativeStock MarketCannabis InvestmentsFundsHealth StocksInvestInvestingMarket StocksMedical Device StocksMedical StocksProfitable InvestmentsProfitable StocksStock MarketStocks to WatchWomen Investors